Shivom
administrator
July 5, 2018

Shivom Partners With SingularityNET For Strengthening Genomics Medical Research and Advanced…

As a step forward towards building the world’s most extensive database of DNA records, we have partnered with SingularityNETso, the pioneers of innovations in AI and deep learning. Popular for being one of the contributors to the development of the world’s first Humanoid ‘Sophia’, SingularityNET’s AI will strengthen our toolset for providing personalized medical analytics by integrating with Shivom’s decentralized network capability.

SingularityNET’s decentralized AI network provides an open market for anyone to develop, share and monetize AI services and algorithms. This is a lucrative alliance for communities in both entities to go full throttle and unlatch optimal benefits.

Shivom Partners With SingularityNET For Strengthening Genomics Medical Research and Advanced

Going Ahead — Strengthening Shivom For The Long Term

Post successful integration of the two networks, AI agents on the SingularityNET’s decentralized platform can request biological datasets from Shivom, to execute certain analytical tasks. Similarly, a Shivom customer can seek AI analytics to be performed on the genomics data uploaded.

Such synergized networks will help boost medical professionals, researchers and the customers needs with a more accurate and more hassle-free understanding of one’s health analysis bypassing impediments in data flow necessary for this type of analysis to take place via 3rd party services.

The cross-disciplinary data sharing amidst the two networks will be driven by automated conversion between the Shivom Tokens and SingularityNET’s AGI Tokens. Followed by deep encryption of datasets in transaction coupled with cross-network reputation management, the fundamental principle of the Blockchain towards data privacy is assured.

” Shivom Co-Founder and CEO, Dr. Axel Schumacher, elaborated on the partnership and said “We are excited to work with SingularityNET. AI approaches are well suited to model the complex dependencies in the regulatory landscape of our genome and can help to predict an individual’s probability of developing certain diseases. Such information should be made actionable. As such, we are confident that AI will play a central role in our platform for achieving greater depth in the interpretation of genetic information such as how an individual’s genes may impact their lifestyle decisions or help their healthcare providers to design of potential therapies.”

SingularityNET CEO, Dr. Ben Goertzel pitched in saying, “ “We are enthused to have the opportunity to support Shivom’s vision of next-era genomic research. The Shivom vision synergizes beautifully with the SingularityNET vision; the integration of Shivom’s technology, tools, and data with our SingularityNET mind-network will add more scope and intelligence into the field of personalized medical analytics.I. Together, we can achieve great things for medical science by utilizing high-quality datasets, SingularityNET’s algorithms and customer base for biomedical analytics services, and Shivom’s genomics-focused software.”

What’s Ahead?

In our mission to unlock the data stored in billions of genetic codes across the globe, this alliance is a breakthrough move. As partners, we really look forward to redefining medical research as we usher in a new era of healthcare and maximize the capabilities of Shivom’s genetic data storage and analysis platform.

Leave a Reply

Your email address will not be published. Required fields are marked *